Theranostic barcoded nanoparticles for personalized cancer medicine
Determining the most effective treatment for each cancer patient is a key challenge in cancer therapy. In this article, the authors show, in a mouse model of breast cancer, that DNA barcoded nanoparticles can be used for pre-screening the efficacy of anticancer drugs.
Bibliographic Details
Main Authors: |
Zvi Yaari,
Dana da Silva,
Assaf Zinger,
Evgeniya Goldman,
Ashima Kajal,
Rafi Tshuva,
Efrat Barak,
Nitsan Dahan,
Dov Hershkovitz,
Mor Goldfeder,
Janna Shainsky Roitman,
Avi Schroeder |
Format: | Article
|
Language: | English |
Published: |
Nature Publishing Group
2016-11-01
|
Series: | Nature Communications
|
Online Access: | https://doi.org/10.1038/ncomms13325
|